GramEye
PrivateLast Round
Series B
Nov 21, 2025
Total Funding Raised
$6.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GramEye is a medical technology company that develops an AI and robotics solution to automate Gram staining, aiming to facilitate the appropriate use of antimicrobials.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Biotech Equipment, Computer Vision
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GramEye Comparables
Compare GramEye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neomend | 71% | |
| bioMérieux | 70% | |
| Bruker | 69% | |
GramEye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 21, 2025 | ||||
| Series A | Oct 13, 2023 |
Key People
Founding team and executive leadership
GramEye Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DEEPCORE Inc. | Series A |
| Ikeda Senshu Capital | Series A |
| Samurai Incubate Inc. | Series A, Series B |
| NES Inc. | Series A, Series B |
| Beyond Next Ventures | Series B |
| STATION Ai Corporation | Series A |
| SMBC Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 46% MoM, reaching 6K.
- Apr 18, 2026
Monthly visitors increased 55% MoM.
GramEye Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GramEye's valuation, stock price, and market status.